CGD Policy Blogs
On December 19th, the MCC Board approved a $235 million compact with Armenia.
The World Bank announced Friday that it was suspending all loans to Chad, including one that helped finance a $4.2 billion oil pipeline, on the ground that it had broken an agreement to largely dedicate its oil revenues to alleviating the country's extreme poverty. According to the Celia Dugger in the NYT
The New England Journal of Medicine reports on tests of vaccines Rotateq and Rotarix involving 130,000 children. The studies found them to be 98% and 85% effective respectively, it says.
"Both vaccines will need to demonstrate their efficacy in the difficult settings of developing countries if we are to achieve our goal of maximally decreasing global deaths from diarrhoea."
There is an interesting discussion at EconLog about the economics of vaccines. This follows a suggestion that some firms might not want to develop a vaccine for diseases such as malaria and AIDS because it is more profitable to sell drugs than prevent the disease with vaccines.
Arnold Kling reaches the same conclusion as the Working Group on Making Markets for Vaccines:
One of the most eloquent, if still little-known, heroes in Zimbabwe is lawyer Beatrice Mtetwa, interviewed here by South Africa’s Mail & Guardian. She has defended many of the leading independent journalists and editors against government repression, including our friend Andy Meldrum who was illegally expelled in May 2003.
Companies have developed two vaccines that theoretically could save the lives of several million children over the next decade, but efforts to get them to the poor countries that need them most are lagging.